MA10 📈 Binect - Overview
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE000A3H2135
MA10: Software, Document Management, Digital Logistics, Receipt Processing
Binect AG provides software and service platform for the digitization of various business document and receipt logistics in Germany. It develops and integrates digital modules and services for medium-sized companies, authorities, and other institutions. The company was founded in 2004 and is based in Weiterstadt, Germany. Web URL: https://www.binect.com
Additional Sources for MA10 Stock
MA10 Stock Overview
Market Cap in USD | 6m |
Sector | Technology |
Industry | Software - Application |
GiC Sub-Industry | Internet & Direct Marketing Retail |
IPO / Inception |
MA10 Stock Ratings
Growth 5y | -0.89% |
Fundamental | 54.4% |
Dividend | - |
Rel. Strength Industry | -205 |
Analysts | - |
Fair Price Momentum | 1.46 EUR |
Fair Price DCF | - |
MA10 Dividends
No Dividends PaidMA10 Growth Ratios
Growth Correlation 3m | -86.1% |
Growth Correlation 12m | -58.8% |
Growth Correlation 5y | -29% |
CAGR 5y | 9.43% |
CAGR/Mean DD 5y | 0.25 |
Sharpe Ratio 12m | -0.70 |
Alpha | -24.29 |
Beta | -0.26 |
Volatility | 56.45% |
Current Volume | 20.1k |
Average Volume 20d | 8.7k |
What is the price of MA10 stocks?
As of December 22, 2024, the stock is trading at EUR 1.67 with a total of 20,062 shares traded.
Over the past week, the price has changed by -8.52%, over one month by -11.54%, over three months by -17.44% and over the past year by -28.13%.
As of December 22, 2024, the stock is trading at EUR 1.67 with a total of 20,062 shares traded.
Over the past week, the price has changed by -8.52%, over one month by -11.54%, over three months by -17.44% and over the past year by -28.13%.
Is Binect a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Binect (XETRA:MA10) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 54.39 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MA10 as of December 2024 is 1.46. This means that MA10 is currently overvalued and has a potential downside of -12.57%.
Partly, yes. Based on ValueRay Fundamental Analyses, Binect (XETRA:MA10) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 54.39 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MA10 as of December 2024 is 1.46. This means that MA10 is currently overvalued and has a potential downside of -12.57%.
Is MA10 a buy, sell or hold?
Binect has no consensus analysts rating.
Binect has no consensus analysts rating.
What are the forecast for MA10 stock price target?
According to ValueRays Forecast Model, MA10 Binect will be worth about 1.6 in December 2025. The stock is currently trading at 1.67. This means that the stock has a potential downside of -5.39%.
According to ValueRays Forecast Model, MA10 Binect will be worth about 1.6 in December 2025. The stock is currently trading at 1.67. This means that the stock has a potential downside of -5.39%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 3.9 | 132.9% |
Analysts Target Price | - | - |
ValueRay Target Price | 1.6 | -5.4% |